Multiple robust signatures for detecting lymph node metastasis in head and neck cancer

Cancer Research

Volumn 66, Issue 4, 2006, Pages 2361-2366

  Roepman, Paul ^a   Kemmeren, Patrick ^a   Wessels, Lodewijk F A ^b,c   Slootweg, Piet J ^d   Holstege, Frank C P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Delft University of Technology ^*  (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MEASUREMENT; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VALIDATION PROCESS;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; RNA, MESSENGER;

EID: 33644507403     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3960     Document Type: Article

References (27)

1. Garber K. Genomic medicine. Gene expression tests foretell breast cancer's future. Science 2004;303:1754-5.
2. Kallioniemi O. Medicine: profile of a tumour. Nature 2004;428:379-82.
3. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6.
4. Ma XJ, Wang Z, Ryan PD, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004;5:607-16.
5. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
6. Caldas C, Aparicio SA. The molecular outlook. Nature 2002;415:484-5.
7. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005;365:488-92.
8. Reid JF, Lusa L, De Cecco L, et al. Limits of predictive models using microarray data for breast cancer clinical treatment outcome. J Natl Cancer Inst 2005;97:927-30.
9. Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer 2004;4:309-14.
10. Miklos GL, Maleszka R. Microarray reality checks in the context of a complex disease. Nat Biotechnol 2004;22:615-21.
11. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
12. Wang Y, Klijn JG, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365:671-9.
13. Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005;37:182-6.
14. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751-8.
15. 0 neck. Br J Oral Maxillofac Surg 1999;37:205-9.
16. Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003;95:14-8.
17. Ein-Dor L, Kela I, Getz G, Givol D, Domany E. Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 2005;21:171-8.
18. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME): toward standards for microarray data. Nat Genet 2001;29:365-71.
19. Spellman PT, Miller M, Stewart J, et al. Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol 2002;3: RESEARCH0046.
20. Kabat GC, Chang CJ, Wynder EL. The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol 1994;23:1137-44.
21. Schlecht NF, Franco EL, Pintos J, Kowalski LP. Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil. Epidemiology 1999;10:412-8.
22. Iizuka N, Oka M, Yamada-Okabe H, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003;361:923-9.
23. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004;4:448-56.
24. Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005;15:87-96.
25. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54.
26. Mueller MM, Fusenig NE. Friends or foes: bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004;4:839-49.
27. Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Cell 2005;7:513-20.